You can always press Enter⏎ to continue
Thanks for your interest in this study!

Thanks for your interest in this study!

13Questions
  • 1
    (Hidden field, for attribution of leads to Lindus, Unite Genomics etc.)
    Press
    Enter
  • 2
    Press
    Enter
  • 3
    Press
    Enter
  • 4
    This could be a letter from a doctor confirming your diagnosis or a copy of your test result from your medical record (positive serologic test for anti-AChR autoantibody).
    Press
    Enter
  • 5
    Press
    Enter
  • 6
    Not shown to users - sets the site id correctly based on the country selected above
    Press
    Enter
  • 7
    Press
    Enter
  • 8
    Press
    Enter
  • 9
    Your consent is necessary in order to proceed. We will never share your data without your explicit consent. We may contact you about relevant future research opportunities, and you can opt-out of this at any time.
    Press
    Enter
  • 10
    In the following questions we will just ask for your name, email, and phone number so that the research team can contact you.
    Press
    Enter
  • 11
    Press
    Enter
  • 12
    In the following questions we will just ask for your name, email, and phone number so that the research team can contact you.
    Press
    Enter
  • 13
    Your mobile number will only be shared with the research team to contact you about this study.
    Press
    Enter
  • 14
    This would include one of the following examples: The IV medication Soliris (eculizumab), the iV or injectable medication Ultomiris (ravulizuman)
    Press
    Enter
  • 15

    Thank you. Please click "SUBMIT" and you will be redirected to our Calendly tool, which you can use to book an appointment with the trial team at a time that is convenient for you. 

     

    If you have any questions, please email meandmgopen@lindushealth.com

    Press
    Enter
  • Should be Empty:
Question Label
1 of 15See AllGo Back
close